HTL-0022562
N/A
Report date: 2024/04/10 16:52:57
NME
Base Information
Drug NameHTL-0022562
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBiohaven Pharmaceuticals IncNxera Pharma UK LtdTeva Pharmaceutical Industries Ltd +[4]
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A